Disease risk prediction for precision healthAXION RESEARCH INC.

CES 2021 Japanese Showcase

Back to Top Page
  • Health & Wellness

Looking For
  • Investor

    Company Phase
    First product launched
    Overseas Business
  • Media

  • Distributor

  • Buyer

  • Partner

Disease risk prediction by dynamic analysis
Predicts disease risk by dynamic analysis of biometric heatmap, not a statistical probability.
Personalized health promotion program
Extracts health inhibiting factors from heatmap and provides the most effective promotion method.
Applicable for early cancer and COVID-19
AXiR Engine is also enabling inference of the risk of early cancer and COVID-19 aggravation.

Company Info

Date of establishment 2016
Capital (USD) 1,641,200
Number of employees 6